
|Articles|December 1, 2012
Stem cells: The not too distant future
Stem cells could successfully treat chronic conditions with significant cost savings.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Robyn Crosson, J.D., Navitus Health Solutions
2
Yesafili, an Eylea biosimilar, launches with a price of $1,445
3
Doravirine-based HIV regimen shows less weight gain than dolutegravir combination, trial finds
4
Genomic testing nearly triples among Medicare patients, but NGS use remains low
5






















